SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950159-12-000145
Filing Date
2012-03-09
Accepted
2012-03-09 14:27:05
Documents
1
Group Members
QUAKER BIOVENTURES CAPITAL II L.P.QUAKER BIOVENTURES CAPITAL II LLC

Document Format Files

Seq Description Document Type Size
1 QUAKER BIOVENTURES II, L.P. SCHEDULE 13-G quakerbio13g.htm SC 13G 116971
  Complete submission text file 0000950159-12-000145.txt   118602
Mailing Address 1033 SKOKIE BLVD SUITE 355 NORTHBROOK IL 60062
Business Address 1033 SKOKIE BLVD SUITE 355 NORTHBROOK IL 60062 224-383-3000
HORIZON PHARMA, INC. (Subject) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86365 | Film No.: 12680157
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G